Meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia in Tampere University hospital: A casecontrol study Finland October 2002 to January 2010

Eurosurveillance

Volumn 16, Issue 35, 2011, Pages

  Rahikka, P ^a   Syrjanen J ^a,b   Vuento, R ^c   Laine, J ^b   Huttunen, R ^a,b  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c PIRKANMAA HOSPITAL DISTRICT   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; CEPHALOSPORIN; CLINDAMYCIN; DAPTOMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; VANCOMYCIN;

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTHRITIS; BACTERIAL STRAIN; BACTERIUM CARRIER; CATHETER INFECTION; CLINICAL CLASSIFICATION; CONTROLLED STUDY; DEVICE INFECTION; DISEASE SEVERITY; ENDOCARDITIS; FEMALE; FINLAND; HEALTH CARE FACILITY; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MCCABE CLASS; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BACTEREMIA; OSTEOMYELITIS; PATIENT TRANSPORT; PUBLIC HOSPITAL; REVIEW; SKIN; STAPHYLOCOCCAL BACTEREMIA; THERAPY DELAY; TREATMENT DURATION; UNIVERSITY HOSPITAL;

EID: 80052777523     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285-92.
2. Viallon A, Marjollet O, Berthelot P, Carricajo A, Guyomarc'h S, Robert F, et al. Risk factors associated with methicillinresistant Staphylococcus aureus infection in patients admitted to the ED. Am J Emerg Med. 2007;25(8):880-6.
3. Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillinresistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28(3):273-9.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1): 53-9.
5. Kerttula AM, Lyytikäinen O, Kardén-Lilja M, Ibrahem S, Salmenlinna S, Virolainen A, et al. Nationwide trends in molecular epidemiology of methicillin-resistant Staphylococcus aureus, Finland, 1997-2004. BMC Infect Dis. 2007;7:94.
6. Stenhem M, Ortqvist A, Ringberg H, Larsson L, Olsson Liljequist B, Haeggman S, et al. Imported methicillinresistant Staphylococcus aureus, Sweden. Emerg Infect Dis. 2010;16(2):189-96.
7. Hulkko T, Lyytikäinen O, Kuusi M, Seppälä S, Ruutu P. Infectious Diseases in Finland 1995-2009. Finnish National Institute for Health and Welfare (THL). Helsinki: THL. 2010. [Accessed 01 Sep 2011]. Available from: http://www.thl.fi/thl-client/pdfs/d6d63c66-9690-4f4d-9ee1-319bb5648eaf
8. Statistics Finland. [Accessed 24 Jul 2011]. Available from: http://www.stat.fi/
9. McCabe WR, Jackson GG. Gram-negative bacteremia. II. Clinical, laboratory, and therapeutic observations. Arch Intern Med. 1962;110(6): 856-64.
10. Ammerlaan H, Seifert H, Harbarth S, Brun-Buisson C, Torres A, Antonelli M, et al. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis. 2009;49(7):997-1005.
11. Arstila T, Auvinen H, Huovinen P. Beta-lactam resistance among Escherichia coli and Klebsiella species blood culture isolates in Finnish hospitals. Finnish Study Group for Antimicrobial Resistance. Eur J Clin Microbiol Infect Dis. 1994;13(6):468-74.
12. Paolucci M, Landini MP, Sambri V. Conventional and molecular techniques for the early diagnosis of bacteraemia. Int J Antimicrob Agents. 2010;36 Suppl 2: S6-16.
13. Marchaim D, Kaye KS, Fowler VG, Anderson DJ, Chawla V, Golan Y, et al. Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2010;16(6):747-52.